Cytokinetics launches Aspen-HCM real-world study evaluating Myqorzo (aficamten) in obstructive HCM

Cytokinetics said it has launched Aspen-HCM, a real-world study evaluating Myqorzo (aficamten) in symptomatic obstructive hypertrophic cardiomyopathy.